Picture of BRAIN Biotech AG logo

BNN BRAIN Biotech AG News Story

0.000.00%
de flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapMomentum Trap

Brief: Brain AG Q1 EBIT Loss Narrows To EUR 1.7 Mln

Feb 15 (Reuters) - BRAIN AG  BNNn.DE : 
    * UNEXPECTEDLY WEAK FIRST QUARTER OF 2017/18 LEADS TO 
DECLINE IN 
REVENUES 
    * REVENUES OF BRAIN AG IN Q1 OF 2017/18 ARE EXPECTED TO 
REACH A 
TOTAL OF EUR 5.3 MILLION 
    * TOTAL OPERATING PERFORMANCE IN Q1 OF 2017/18 IS EXPECTED 
TO BE 
EUR 6.0 MILLION, DOWN 8.7% YEAR-ON-YEAR 
    * Q1  EBIT IMPROVED BY AN ESTIMATED EUR 0.6 MILLION TO EUR 
-1.7 
MILLION 
    * NOW APPEARS UNLIKELY THAT EBIT BREAK-EVEN TARGET WILL BE 
REACHED 
IN COURSE OF 2017/18 FINANCIAL YEAR 
    * STILL EXPECTS TO ACHIEVE DOUBLE-DIGIT REVENUE GROWTH IN 
2017/18, 
ALTHOUGH BELOW PREVIOUS EXPECTATIONS 
 
Source text for Eikon:  ID:nEQ36tGTfa  
Further company coverage:  BNNn.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 702 09 20;))

Recent news on BRAIN Biotech AG

See all news